What investment strategy does KIZOO Technology Capital focus on?

KIZOO Technology Capital focuses on VC strategies in the private equity space.

How many portfolio companies does KIZOO Technology Capital have?

KIZOO Technology Capital has 11 active portfolio companies and 2 completed exits and 1 fund tracked on GP Intel.

Where is KIZOO Technology Capital headquartered?

KIZOO Technology Capital is headquartered in Karlsruhe, Germany.

When was KIZOO Technology Capital founded?

KIZOO Technology Capital was founded in 2007.

What sectors does KIZOO Technology Capital invest in?

KIZOO Technology Capital invests across Healthcare, Software, TMT.

Home/GPs/KIZOO Technology Capital

DetailCard

KIZOO Technology Capital

Karlsruhe, Germany·Founded 2007·

Venture Capital

·kizoo.com

KIZOO Technology Capital is a Karlsruhe-based evergreen venture investor founded by internet entrepreneur Michael Greve. Structured as a family-equity vehicle within Mira Holding, it invests off its own balance sheet without external LPs. Since founder Greve launched the Forever Healthy Foundation in 2015, KIZOO has focused exclusively on rejuvenation and longevity biotech, providing seed and follow-on capital to companies developing therapies that repair or reverse age-related cellular damage. In 2021 Greve committed an additional EUR 300 million (about USD 362 million) to build out this portfolio. KIZOO also retains large legacy stakes in German internet and SaaS companies it seeded in its earlier IT era, including Babbel, Mambu and Staffbase.

AUM

–

Funds

vintages 2007

Portfolio

Exits

KIZOO Technology Capital is a Karlsruhe venture capital firm with 11 active companies and 2 exits.

SectorsHealthcare Software TMT

Sector breakdown

13 companies

Biotech

9 · 69%

EdTech

1 · 8%

Fintech

1 · 8%

Mobility

1 · 8%

HR Tech

1 · 8%

Geography breakdown

3 geographies

6 · 46%

Germany

5 · 38%

Switzerland

2 · 15%

Key facts

HQKarlsruhe, Germany

Founded2007

Websitekizoo.com

Recent exits

KIZOO Technology Capital took MAIA Biotechnology public in 2022 after 3 years.

KIZOO Technology Capital took AgeX Therapeutics public in 2018 after 1 year.

Coverage notes

1 fund tracked, 13 portfolio companies (11 active · 2 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund KIZOO Technology Capital has raised, with its portfolio companies. Hand-checked from public filings.

1 fund

Fund

Strategy

Vintage

Size

Assets

Exits

KIZOO Evergreen (Balance Sheet)Active

Evergreen2007€300M11 assets2 exits

Evergreen

2007 · 19yr

€300M

Unrealized

11 held

Company	Entry
Babbel EdTech · Germany	2008
Cellvie Biotech · Switzerland	2021
Cyclarity Therapeutics Biotech · US	2019
Elastrin Therapeutics Biotech · US	2021
Mambu Fintech · Germany	2011
MoglingBio Biotech · Germany	2022
MOQO Mobility · Germany	2019
PAGE Therapeutics AG Biotech · Switzerland	2023
Reservoir Neuroscience Biotech · US	2024
Revel Pharmaceuticals Biotech · US	2020
Staffbase HR Tech · Germany	2015

Realized

2 exits

Company	Entry	Exit	Type	Buyer	MOIC
AgeX Therapeutics Biotech · US	2017	2018	IPO	–	–
MAIA Biotechnology Biotech · US	2019	2022	IPO	–	–

Frequently asked questions

What investment strategy does KIZOO Technology Capital focus on?: KIZOO Technology Capital focuses on VC strategies in the private equity space.
How many portfolio companies does KIZOO Technology Capital have?: KIZOO Technology Capital has 11 active portfolio companies and 2 completed exits and 1 fund tracked on GP Intel.
Where is KIZOO Technology Capital headquartered?: KIZOO Technology Capital is headquartered in Karlsruhe, Germany.
When was KIZOO Technology Capital founded?: KIZOO Technology Capital was founded in 2007.
What sectors does KIZOO Technology Capital invest in?: KIZOO Technology Capital invests across Healthcare, Software, TMT.